Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy

Khan Faheem Ahmed, Pandupuspitasari Nuruliarizki Shinta, Tencomnao Tewin, Chuchawankul Siriporn

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (93)

  1. Psilocybin and chronic neuropathic pain: a systematic review. 2025-11-05 · Expand citations
  2. Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective. 2025-02-01 · Expand citations
  3. Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management. 2025-01-07 · Expand citations
  4. Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics. 2025-01-01 · Expand citations
  5. Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin. 2024-07-01 · Expand citations
  6. Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity. 2024-05-15 · Expand citations
  7. Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians. 2024-04-24 · Expand citations
  8. Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis. 2024-04-01 · Expand citations
  9. Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study. 2024-02-07 · Expand citations
  10. Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists 2024-01-21 · Expand citations
  11. Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions? 2024-01-01 · Expand citations
  12. Safety pharmacology of acute psilocybin administration in healthy participants. 2024-01-01 · Expand citations
  13. Molecular and Medical Aspects of Psychedelics. 2023-12-23 · Expand citations
  14. Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity. 2023-12-20 · Expand citations
  15. Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats. 2023-12-14 · Expand citations
  16. Cardiovascular safety of psychedelic medicine: current status and future directions. 2023-12-01 · Expand citations
  17. Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings. 2023-12-01 · Expand citations
  18. Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. 2023-09-01 · Expand citations
  19. Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use. 2023-07-01 · Expand citations
  20. Default Mode Network Modulation by Psychedelics: A Systematic Review. 2023-03-22 · Expand citations
  21. Therapeutic effect of psilocybin in addiction: A systematic review. 2023-01-01 · Expand citations
  22. Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. 2022-11-11 · Expand citations
  23. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. 2022-11-03 · Expand citations
  24. Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic Perspective 2022-10-10 · Expand citations
  25. Serotonin 5-HT, 5-HT and 5-HT receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response. 2022-10-01 · Expand citations
  26. Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior. 2022-06-16 · Expand citations
  27. Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence. 2022-05-18 · Expand citations
  28. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. 2022-03-15 · Expand citations
  29. Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective? 2022-02-07 · Expand citations
  30. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. 2022-02-01 · Expand citations
  31. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation. 2022-01-01 · Expand citations
  32. Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals. 2022-01-01 · Expand citations
  33. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. 2022-01-01 · Expand citations
  34. Psilocybin for Trauma-Related Disorders. 2022-01-01 · Expand citations
  35. The Therapeutic Potential of Psilocybin. 2021-05-15 · Expand citations
  36. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
  37. Psilocybin and MDMA for the treatment of trauma-related psychopathology. 2021-05-01 · Expand citations
  38. A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain. 2021-01-15 · Expand citations
  39. Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms. 2021-01-01 · Expand citations
  40. The emerging role of psilocybin and MDMA in the treatment of mental illness. 2020-12-01 · Expand citations
  41. Psilocybin: from ancient magic to modern medicine. 2020-10-01 · Expand citations
  42. Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials. 2020-09-05 · Expand citations
  43. Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Magic Mushroom. 2020-08-31 · Expand citations
  44. Reviewing the Potential of Psychedelics for the Treatment of PTSD. 2020-06-24 · Expand citations
  45. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. 2020-04-01 · Expand citations
  46. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. 2020-02-01 · Expand citations
  47. The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis. 2020-02-01 · Expand citations
  48. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. 2020-02-01 · Expand citations
  49. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. 2019-10-24 · Expand citations
  50. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. 2019-08-01 · Expand citations
  51. Effects of psilocybin therapy on personality structure. 2018-11-01 · Expand citations
  52. Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. 2018-07-01 · Expand citations
  53. Psychedelic use and intimate partner violence: The role of emotion regulation. 2018-07-01 · Expand citations
  54. Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? 2018-05-01 · Expand citations
  55. The relationships of classic psychedelic use with criminal behavior in the United States adult population. 2018-01-01 · Expand citations
  56. Effect of Psilocybin on Empathy and Moral Decision-Making. 2017-09-01 · Expand citations
  57. Clinical potential of psilocybin as a treatment for mental health conditions. 2017-01-01 · Expand citations
  58. Psilocybin and palliative end-of-life care. 2016-12-01 · Expand citations
  59. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  60. Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip. 2016-12-01 · Expand citations
  61. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  62. The role of psychedelics in palliative care reconsidered: A case for psilocybin. 2016-12-01 · Expand citations
  63. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  64. Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. 2015-10-15 · Expand citations
  65. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. 2015-03-01 · Expand citations
  66. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  67. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. 2011-12-01 · Expand citations
  68. The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. 2011-11-01 · Expand citations
  69. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  70. Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. 2007-12-01 · Expand citations
  71. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  72. Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. 2004-03-01 · Expand citations
  73. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. 1998-12-01 · Expand citations
  74. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. 1997-05-01 · Expand citations
  75. Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen 1959-01-01 · Expand citations
  76. 10.1002/jclp.20000
  77. 10.1002/prp2.688
  78. 10.1016/j.jadr.2021.100240
  79. 10.1016/j.neuropharm.2022.109174
  80. 10.1016/s2215-0366(24)00203-7
  81. 10.1038/s41380-023-02291-w
  82. 10.1038/s41386-021-01155-7
  83. 10.1080/15265161.2024.2433428
  84. 10.1111/bcp.16045
  85. 10.1136/rapm-2020-101273
  86. 10.1176/appi.ajp.20230787
  87. 10.1176/appi.ajp.20230914
  88. 10.1177/0269881116642538
  89. 10.1177/13634615221100385
  90. 10.1186/s10020-024-01013-4
  91. 10.1353/ppp.2021.0032
  92. 10.25166/ijsrm/2022.20.3.2
  93. 10.3389/fpain.2025.1527783

Cited by — these papers cite this paper (4)

  1. Cannabis and Psilocybin Co-use: Associations with Stress and Well-being 2026-10-13 · Expand citations
  2. Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation service 2026-09-16 · Expand citations
  3. The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing 2026-08-19 · Expand citations
  4. Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA 2026-06-15 · Expand citations